Clinical effect of nonthrombotic total parenteral nutrition catheters.
Radiographic evidence of subclavian vein thrombosis has been shown to occur in 33% of total parenteral nutrition patients. This incidence can be significantly reduced to 8% when heparin is administered concomitantly in total parenteral nutrition solutions. To evaluate the thrombotic risk of a newly developed polyurethane catheter, 20 concurrent patient pairs were prospectively cannulated with either a standard polyethylene catheter plus heparin or a polyurethane catheter without heparin in a sequential statistical study. Radionuclide venograms (Tc99m) were performed within 72 hr of catheterization, at biweeky intervals, and at termination of total parenteral nutrition administration. No patient in either group developed clinical (pain, arm swelling, collateral veins) or venogram evidence of thrombosis after catheterization during an overall cannulation period of 820 days. Use of polyurethane catheters and elimination of heparin in total parenteral solutions may be particularly important since contraindications to heparin use are common. Additionally, heparin elimination can decrease admixture work and confusion (ie, subcutaneous heparin double dosing) without increasing the risk of subclavian vein thrombosis.
D000328:Adult; D000368:Aged; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition / Q000295:instrumentation*; D010289:Parenteral Nutrition, Total / Q000295:instrumentation*; D011095:Polyethylenes; D011140:Polyurethanes; D011446:Prospective Studies; D011897:Random Allocation; D012306:Risk; D013350:Subclavian Vein; D013927:Thrombosis / Q000517:prevention & control*; D013997:Time Factors
D011095:Polyethylenes; D011140:Polyurethanes; D006493:Heparin